The resistance mechanisms of proteasome inhibitor bortezomib
Author:
Publisher
Springer Science and Business Media LLC
Subject
Biochemistry (medical),Clinical Biochemistry,Molecular Medicine
Link
http://link.springer.com/content/pdf/10.1186/2050-7771-1-13.pdf
Reference56 articles.
1. Voges D, Zwickl P, Baumeister W: The 26S proteasome: a molecular machine designed for controlled proteolysis. Ann Rev Biochem 1999, 68: 1015–1068. 10.1146/annurev.biochem.68.1.1015
2. Daniel KG, Kuhn DJ, Kazi A, Dou QP: Anti-angiogenic and anti-tumor properties of proteasome inhibitors. Curr Cancer Drug Targets 2005, 5: 529–541. 10.2174/156800905774574075
3. Kisselev AF, Akopian TN, Castillo V, Goldberg AL: Proteasome active sites allosterically regulate each other, suggesting a cyclical bite-chew mechanism for protein breakdown. Mol Cell 1999, 4: 395–402. 10.1016/S1097-2765(00)80341-X
4. Rajkumar SV, Richardson PG, Hideshima T, Anderson KC: Proteasome inhibition as a novel therapeutic target in human cancer. J Clin Oncol 2005, 23: 630–639.
5. Rivett AJ: The multicatalytic proteinase. Multiple proteolytic activities. J Biol Chem 1989, 264: 12215–12219.
Cited by 127 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Acute accumulation of PIM2 and NRF2 and recovery of β5 subunit activity mitigate multiple myeloma cell susceptibility to proteasome inhibitors;International Journal of Hematology;2024-01-21
2. Targeting gut microbial nitrogen recycling and cellular uptake of ammonium to improve bortezomib resistance in multiple myeloma;Cell Metabolism;2024-01
3. Proteasome inhibitors as anticancer agents;Expert Opinion on Therapeutic Patents;2023-10-30
4. Ancistrocladinium A Induces Apoptosis in Proteasome Inhibitor-Resistant Multiple Myeloma Cells: A Promising Therapeutic Agent Candidate;Pharmaceuticals;2023-08-18
5. New trends in synthetic drugs and natural products targeting 20S proteasomes in cancers;Bioorganic Chemistry;2023-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3